20 Nov 2023
08:30 CET |
SOLVAY |
Solvay announces the publication of a supplement to its information document
|
55201000 Chemicals: Diversified |
Corporate life |
20 Nov 2023
07:10 CET |
JENSEN-GROUP |
Inkoop eigen aandelen - wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
20 Nov 2023
07:10 CET |
JENSEN-GROUP |
Share buyback – weekly update
|
50204000 Machinery: Industrial |
Other subject |
20 Nov 2023
07:00 CET |
OXURION |
Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
|
20103010 Biotechnology |
- |
19 Nov 2023
21:00 CET |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
- |
17 Nov 2023
22:15 CET |
EURONAV |
Questions in relation to upcoming special general meeting
|
50206030 Marine Transportation |
Other subject |
17 Nov 2023
22:15 CET |
EURONAV |
Vragen met betrekking tot aanstaande bijzondere algemene vergadering
|
50206030 Marine Transportation |
Other subject |
17 Nov 2023
07:45 CET |
BEKAERT |
Bekaert annonce la huitième tranche de son Programme de Rachat d'Actions
|
55102010 Iron and Steel |
Legal |
17 Nov 2023
07:45 CET |
BEKAERT |
Bekaert kondigt de achtste tranche van haar inkoopprogramma eigen aandelen aan
|
55102010 Iron and Steel |
Legal |
17 Nov 2023
07:45 CET |
BEKAERT |
Bekaert announces the eighth tranche of its Share Buyback Program
|
55102010 Iron and Steel |
Legal |
17 Nov 2023
07:00 CET |
BEKAERT |
Bekaert: Rapport d’activités sur les neuf mois jusqu’à septembre 2023
|
55102010 Iron and Steel |
Sales |
17 Nov 2023
07:00 CET |
BEKAERT |
Bekaert: Activiteitenverslag eerste negen maanden tot en met september 2023
|
55102010 Iron and Steel |
Sales |
17 Nov 2023
07:00 CET |
BEKAERT |
Bekaert: Trading update for the nine months to September 2023
|
55102010 Iron and Steel |
Sales |
17 Nov 2023
06:30 CET |
EVS BROADC.EQUIPM. |
Points sur résultats de l’activité du 3ème trimestre d’EVS
|
15101010 Telecommunications Equipment |
Corporate life |
17 Nov 2023
06:30 CET |
EVS BROADC.EQUIPM. |
EVS Q3 2023 business update
|
15101010 Telecommunications Equipment |
Corporate life |
16 Nov 2023
19:00 CET |
OXURION |
Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year
|
20103010 Biotechnology |
- |
16 Nov 2023
19:00 CET |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
- |
16 Nov 2023
18:05 CET |
PAYTON PLANAR MAGNETICS |
PR Q3 2023
|
50202010 Electrical Components |
Income |
16 Nov 2023
18:00 CET |
AZELIS GROUP NV |
Azelis Group NV: Transparantiekennisgeving
|
55201000 Chemicals: Diversified |
Other subject |
16 Nov 2023
18:00 CET |
AZELIS GROUP NV |
Azelis Group NV: Transparency Notification
|
55201000 Chemicals: Diversified |
Other subject |
16 Nov 2023
17:53 CET |
CENERGY |
TRADING UPDATE Q3 2023
|
50202010 Electrical Components |
Commercial results |
16 Nov 2023
17:52 CET |
CENERGY |
TRADING UPDATE Q3 2023
|
50202010 Electrical Components |
Commercial results |
16 Nov 2023
13:40 CET |
ARGENX SE |
argenx Announces European Commission Approval of Subcutaneous VYVGART® (efgartigimod alfa) for Generalized Myasthenia Gravis
|
20103010 Biotechnology |
Other subject |
16 Nov 2023
08:30 CET |
SOLVAY |
Syensqo annonce l’approbation du prospectus relatif à l’admission des actions Syensqo aux négociations sur Euronext Bruxelles et Euronext Paris
|
55201000 Chemicals: Diversified |
Corporate life |
16 Nov 2023
08:30 CET |
SOLVAY |
Syensqo kondigt goedkeuring van het prospectus in verband met de notering van haar aandelen op Euronext Brussel en Parijs aan
|
55201000 Chemicals: Diversified |
Corporate life |
16 Nov 2023
08:30 CET |
SOLVAY |
Syensqo announces approval of the prospectus relating to the listing of Syensqo shares on Euronext Brussels and Euronext Paris
|
55201000 Chemicals: Diversified |
Corporate life |
16 Nov 2023
07:30 CET |
ONWARD MEDICAL |
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
|
20101025 Health Services |
- |
16 Nov 2023
07:30 CET |
ONWARD MEDICAL |
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
|
20101025 Health Services |
- |
16 Nov 2023
07:30 CET |
ONWARD MEDICAL |
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
|
20101025 Health Services |
- |
16 Nov 2023
07:30 CET |
ONWARD MEDICAL |
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
|
20101025 Health Services |
- |
16 Nov 2023
07:00 CET |
ION BEAM APPLICATIONS |
IBA déclaration intermédiaire - Troisième trimestre 2023
|
20102010 Medical Equipment |
Commercial results |
16 Nov 2023
07:00 CET |
UNIFIEDPOST GROUP SA/NV |
Unifiedpost Group reports strong Q3 2023 performance and strategic progress
|
10101010 Computer Services |
Commercial results |
16 Nov 2023
07:00 CET |
ION BEAM APPLICATIONS |
IBA Business Update – Third Quarter 2023
|
20102010 Medical Equipment |
Commercial results |
15 Nov 2023
19:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
|
20103010 Biotechnology |
- |
15 Nov 2023
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
15 Nov 2023
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
15 Nov 2023
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
15 Nov 2023
17:51 CET |
CENERGY |
Conférence téléphonique portant sur les résultats financiers du troisième trimestre 2023 destinée aux investisseurs et analystes
|
50202010 Electrical Components |
General meeting / Board Meeting |
15 Nov 2023
17:48 CET |
CENERGY |
Trading Update Q3 2023 Conference Call for investors and analysts
|
50202010 Electrical Components |
Meetings / events |
15 Nov 2023
07:45 CET |
AGFA-GEVAERT |
The Agfa-Gevaert Group in Q3 2023: overall EBITDA growth driven by strong performance of the growth engines, while film business under pressure
|
50202025 Electronic Equipment: Gauges and Meters |
Other subject |
15 Nov 2023
07:45 CET |
AGFA-GEVAERT |
De Agfa-Gevaert Groep in het derde kwartaal van 2023: algemene groei EBITDA dankzij sterke prestatie groeimotoren, filmactiviteiten onder druk
|
50202025 Electronic Equipment: Gauges and Meters |
Other subject |
14 Nov 2023
22:09 CET |
MIKO |
Miko acquires Capriole Coffee Service.
|
45101020 Soft Drinks |
Mergers, Acquiqitions, Transferts |
14 Nov 2023
22:08 CET |
MIKO |
Miko acquiert Capriole Coffee Service.
|
45101020 Soft Drinks |
Mergers, Acquiqitions, Transferts |
14 Nov 2023
22:07 CET |
MIKO |
Miko neemt Capriole Coffee Service over.
|
45101020 Soft Drinks |
Mergers, Acquiqitions, Transferts |
14 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
Other subject |
14 Nov 2023
22:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
Other subject |
14 Nov 2023
22:00 CET |
MDXHEALTH |
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
|
20103010 Biotechnology |
Meetings / events |
14 Nov 2023
19:00 CET |
MELEXIS |
Wijzigingen doorgevoerd in de aandeelhoudersstructuur
|
10102010 Semiconductors |
Corporate life |
14 Nov 2023
19:00 CET |
MELEXIS |
Changes to the Shareholding Structure
|
10102010 Semiconductors |
Corporate life |
14 Nov 2023
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |